Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Arthritis Rheumatol. 2017 Aug 8;69(9):1871–1878. doi: 10.1002/art.40171

Table 3.

Extended multivariable analysis of predictive significance of CCL2 and IL-10 for rate of change in FVC% in GENISOS cohort *

Cytokine b 95% CI p-value
Time: CCL2 −0.69 (−1.24; −0.15) 0.013
Time: IL10 0.28 (0.09; 0.47) 0.004
Time 1.41 (−0.98; 3.80) 0.248
CCL2 −2.79 (−7.07; 1.50) 0.202
IL10 −2.19 (−3.76; −0.63) 0.006
Diffuse −5.24 (−10.49; 0.01) 0.051
Immunosuppression −8.44 (−13.69; −3.20) 0.002
Topo I −4.92 (−11.79; 1.95) 0.160
LnCRP −3.23 (−4.96; −1.51) <0.001
*

Adjusted for age at enrollment, gender, and African American race